Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BMO Capital Maintains Outperform on Celestica, Raises Price Target to $37

Author: Benzinga Newsdesk | January 31, 2024 01:34pm
BMO Capital analyst Thanos Moschopoulos maintains Celestica (NYSE:CLS) with a Outperform and raises the price target from $32 to $37.

Posted In: CLS TSX:CLS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist